We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

168 hedge funds and large institutions have $1.57B invested in Amedisys in 2016 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 59 increasing their positions, 67 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $3.14M | Put options by funds: $2.07M

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

7% more capital invested

Capital invested by funds: $1.46B → $1.57B (+$108M)

0% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 21

1% less funds holding

Funds holding: 169 → 168 (-1)

12% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 67

Holders
168
Holders Change
-1
Holders Change %
-0.59%
% of All Funds
4.48%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
21
Increased
59
Reduced
67
Closed
21
Calls
$3.14M
Puts
$2.07M
Net Calls
+$1.07M
Net Calls Change
+$3.32M

Top Buyers

1
Wells Fargo
Wells Fargo
California
+$79.1M
2
Marshall Wace
Marshall Wace
United Kingdom
+$6.26M
3
LOAMS
Lombard Odier Asset Management (Switzerland)
Switzerland
+$5.44M
4
NFA
Nationwide Fund Advisors
Ohio
+$5.33M
5
RIM
Rainier Investment Management
Washington
+$4.16M

Top Sellers

1
NTC
North Tide Capital
Massachusetts
-$24.2M
2
GAM
Gotham Asset Management
New York
-$8.99M
3
EAM
EverPoint Asset Management
Connecticut
-$7.49M
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$5.99M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$4.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
TC
176
TFS Capital
Pennsylvania
– -$1.27M -26,364 Closed
SDIC
177
South Dakota Investment Council
South Dakota
– -$933K -19,300 Closed
PRCP
178
Pacific Ridge Capital Partners
Oregon
– -$814K -16,840 Closed
Connor, Clark & Lunn Investment Management (CC&L)
179
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$763K -15,775 Closed
CCMH
180
Cornerstone Capital Management Holdings
New York
– -$575K -11,900 Closed
DC
181
Deere & Company
Illinois
– -$535K -11,065 Closed
EMG
182
Ellington Management Group
Connecticut
– -$512K -10,600 Closed
PA
183
Perceptive Advisors
New York
– -$507K -10,493 Closed
PC
184
Palo Capital
California
– -$238K -4,931 Closed
Walleye Trading
185
Walleye Trading
New York
– -$75.4K -1,493 Closed
CSS
186
Cubist Systematic Strategies
Connecticut
– -$52K -1,075 Closed
HDIM
187
Hanson & Doremus Investment Management
Vermont
– -$18K -365 Closed
IA
188
IFP Advisors
Florida
– -$37K -305 Closed
GAM
189
Gemmer Asset Management
California
– -$6K -140 Closed
4 5 6 7
8

AMED Hedge Fund Activity: Q2 2016 in Review

168 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2016, worth a combined $1.57B — up 7.4% from $1.46B a quarter earlier.

Fund positioning in AMED was balanced in Q2 2016: 21 funds opened new positions, 21 closed out, 59 added to existing stakes and 67 trimmed.

The largest buyer was Wells Fargo, adding an estimated $79.1M. The largest seller was North Tide Capital, exiting entirely with an estimated $24.2M sold.

  • 168 institutional investors held Amedisys (AMED) as of Q2 2016, down from 169 in Q1 2016.
  • Funds reported $1.57B of Amedisys stock for Q2 2016, up 7.4% quarter-over-quarter.
  • 21 funds opened new Amedisys positions in Q2 2016 and 21 closed out, a net change of 0 holders.
  • The largest Amedisys buyer in Q2 2016 was Wells Fargo, an estimated $79.1M added.
  • The largest Amedisys seller in Q2 2016 was North Tide Capital, an estimated $24.2M sold.

Based on aggregated 13F filings for Q2 2016.